Erectile Dysfunction Isn’t Always About Testosterone

One of the most important distinctions in evaluating sexual dysfunction is the difference between sexual desire and erectile function.

Libido describes sexual interest or desire.

Erectile function is more complex.

Sexual arousal begins in the brain, where sensory input, sexual thoughts, emotions, relationship dynamics, stress, anxiety, and previous experiences can influence the signals that ultimately produce an erection.

Those signals travel through the nervous system and trigger vascular changes within the penis that increase blood flow and produce rigidity.

Hormones influence this entire system, but they are only one component.

These are related problems, but they are not interchangeable.

Importantly, erectile dysfunction should not always be divided neatly into either “physical” or “psychological.”

In many men, the two interact.

A mild physical change in erectile function can create performance anxiety. That anxiety can change autonomic nervous-system activity, making an erection more difficult to obtain or maintain. The next unsuccessful experience can then increase anxiety further, creating a self-reinforcing cycle.

The autonomic nervous system regulates many processes that occur without conscious control, including heart rate, blood pressure, digestion—and important aspects of sexual function.

Both are necessary for normal sexual function.

But they perform different roles.

Parasympathetic signaling plays an important role in initiating and maintaining an erection.

During sexual arousal, parasympathetic pathways originating from the sacral spinal cord help activate nerves supplying the erectile tissue.

This promotes nitric oxide signaling and relaxation of smooth muscle within the penile arteries and corpora cavernosa.

The result is increased penile blood flow.

As the erectile tissue fills and expands, venous outflow becomes compressed, helping trap blood within the penis and maintain rigidity.

This is one reason erections generally occur more easily when someone feels comfortable, engaged, relaxed, and sexually stimulated.

The sympathetic nervous system has a different role in male sexual function.

As sexual stimulation progresses toward climax, sympathetic activity increases and contributes importantly to emission and ejaculation.

During emission, sympathetic pathways help coordinate contraction of structures including the vas deferens, seminal vesicles, and prostate, moving seminal fluid into the posterior urethra.

Ejaculation then involves a coordinated reflex that includes sympathetic, parasympathetic, and somatic pathways.

Orgasm occurs alongside this process but is not simply a sympathetic reflex. It is a complex sensory and neurologic experience involving the brain, spinal cord, autonomic nervous system, and somatic nervous system.

Both systems are necessary—but the balance between them matters.

The sympathetic nervous system does not only become active during ejaculation.

This creates an important connection between psychology and erectile physiology.

A man may be sexually interested in his partner and physically capable of having an erection.

But if he becomes anxious about his performance, his sympathetic nervous system may become increasingly activated.

That sympathetic activity can oppose some of the parasympathetic and vascular processes favoring erection.

Instead of the body remaining in a state conducive to penile smooth-muscle relaxation and blood filling, increasing sympathetic tone can favor smooth-muscle contraction and loss of erectile rigidity.

That is not simply “in his head.”

It is the brain changing autonomic nervous-system activity, which then changes vascular physiology.

The changing balance between autonomic pathways also helps explain what happens as sexual activity progresses.

Early sexual arousal generally favors the neural and vascular pathways necessary for erection.

As stimulation increases toward ejaculation, sympathetic activity becomes increasingly important.

Following ejaculation and orgasm, the penis normally transitions toward detumescence, or loss of the erection.

Smooth muscle contracts, arterial inflow decreases, venous drainage resumes, and penile pressure falls.

This transition is part of normal male sexual physiology.

So the autonomic nervous system is not simply turning an erection “on” or “off.”

Different neural pathways become more or less prominent during different phases of the sexual response.

When evaluating male sexual dysfunction, testosterone frequently receives most of the attention.

That makes sense because testosterone is important for libido, sexual signaling, spontaneous erections, mood, energy, body composition, and other aspects of male health.

But male hormonal physiology is more complicated than a testosterone number.

Hormones should therefore be interpreted as part of an interconnected endocrine system rather than as isolated laboratory values.

Estrogen is sometimes discussed as though it were exclusively a female hormone.

It is not.

Men normally produce estradiol, primarily through conversion of testosterone by the enzyme aromatase.

The relationship between estradiol and male sexual function is complex.

Higher estradiol levels have been associated with erectile dysfunction in some observational studies, but this does not establish that estradiol itself is always the cause. Obesity, increased aromatase activity, metabolic disease, lower testosterone, and other factors can occur at the same time.

At the opposite extreme, estradiol that is suppressed too aggressively may also negatively affect sexual function.

The goal therefore should not automatically be to lower estrogen.

It should be to understand the patient’s overall hormonal physiology.

A portion of circulating testosterone is converted into estradiol through aromatization.

This means testosterone and estradiol should not always be viewed as opposing hormones.

They are biologically interconnected.

When testosterone levels increase, particularly during testosterone therapy, estradiol may also increase because more testosterone is available for aromatization.

That increase is not automatically pathological.

Treating an estradiol laboratory number without considering the entire hormonal environment can oversimplify male endocrine physiology.

Aromatase inhibitors reduce the conversion of testosterone into estradiol.

They can be appropriate in selected clinical situations, but they should not automatically be prescribed simply because estradiol increases during testosterone therapy.

Excessive suppression of estradiol may have consequences.

Estradiol contributes to bone metabolism and other aspects of male physiology, and very low estradiol may potentially contribute to changes in libido, sexual function, mood, or musculoskeletal health in some men.

Instead, hormonal treatment should attempt to maintain an appropriate physiologic balance while considering symptoms and the clinical situation.

Prolactin is another hormone that can sometimes be overlooked.

Significantly elevated prolactin can suppress hypothalamic and pituitary signaling, potentially lowering testosterone production and affecting libido and sexual function.

Not every man with ED requires extensive prolactin testing.

But in the appropriate clinical setting—particularly when ED is accompanied by low libido or unexplained testosterone deficiency—prolactin may be relevant.

Both hypothyroidism and hyperthyroidism have been associated with sexual dysfunction.

Again, this does not mean every case of ED is caused by thyroid disease.

It illustrates why reducing male sexual function to a single testosterone measurement can miss important physiology.

For many men, erectile dysfunction has an important vascular component.

A normal erection requires more than simply getting enough blood into the penis.

Problems with either process can cause erectile dysfunction.

During sexual arousal, nitric oxide signaling causes smooth muscle within the penile arteries and erectile tissue to relax.

This allows arterial blood flow into the corpora cavernosa to increase dramatically.

Conditions that impair vascular health can reduce this response.

Many of these conditions are associated with endothelial dysfunction.

The endothelium is the thin cellular lining inside blood vessels and plays an important role in vascular tone and nitric oxide signaling.

When endothelial function becomes impaired, the penile arteries may not dilate adequately during sexual stimulation.

The result may be an erection that develops slowly, never becomes completely firm, or cannot be achieved at all.

But getting blood into the penis is only half of the equation.

Once blood enters the corpora cavernosa, the erectile tissue expands.

As it expands, it compresses the small veins that normally drain blood from the penis against the surrounding tunica albuginea, the dense fibrous tissue surrounding the corpora cavernosa.

This is known as the veno-occlusive mechanism.

By restricting venous outflow, pressure builds within the corpora cavernosa and the penis becomes rigid.

If this veno-occlusive mechanism does not function properly, blood may enter the penis normally but leave too quickly to maintain adequate pressure.

This is commonly referred to as a “venous leak.”

A more precise term is veno-occlusive dysfunction.

A man with impaired arterial inflow may have difficulty developing an erection in the first place.

A man with veno-occlusive dysfunction may experience a somewhat different pattern.

He may be able to obtain an erection initially but have difficulty maintaining it.

These patterns can provide clues, but symptoms alone cannot reliably distinguish arterial insufficiency from veno-occlusive dysfunction.

The two can also occur together.

The term venous leak can be somewhat misleading.

It may sound as though there is simply a defective vein that needs to be closed.

In reality, normal erectile rigidity depends on the entire corporal veno-occlusive mechanism.

The erectile smooth muscle must relax appropriately, the corpora cavernosa must expand, and the subtunical veins must become sufficiently compressed against the tunica albuginea.

Abnormalities involving smooth-muscle function, structural changes within the erectile tissue, the tunica albuginea, or venous drainage can interfere with this process.

So the problem is often better understood as failure to adequately trap blood within the erectile tissue, rather than simply a vein that is “leaking.”

The distinction between arterial inflow and veno-occlusion is useful, but these systems are not completely independent.

Strong arterial inflow helps expand the corpora cavernosa sufficiently to compress venous outflow.

If arterial inflow is inadequate, the erectile tissue may never expand enough to fully engage the veno-occlusive mechanism.

Likewise, excellent arterial inflow cannot produce a durable erection if blood cannot be adequately retained.

This is why evaluating vascular erectile dysfunction sometimes requires looking beyond the simple question of whether a man has “good circulation.”

The issue may be blood coming in, blood staying in, or both.

This is one of the most important reasons erectile dysfunction should not automatically be treated as simply a hormonal problem.

ED and cardiovascular disease share many of the same risk factors and biological mechanisms, particularly vascular and endothelial dysfunction.

Research suggests that erectile dysfunction may precede clinically apparent cardiovascular disease by several years in some men.

This does not mean every man with erectile dysfunction has heart disease.

It means that new or unexplained erectile dysfunction—particularly in someone with cardiovascular risk factors—may provide an opportunity to look more carefully at overall metabolic and cardiovascular health.

Sometimes the most important question is not simply:
“How do we improve the erection?”

It is:
“Why has erectile function changed?”

Diabetes is particularly important in erectile dysfunction because it can affect several components of normal erectile physiology simultaneously.

A man with diabetes may therefore experience ED because of both vascular and neurologic dysfunction.

Insulin resistance, obesity, and metabolic syndrome may contribute even before someone develops overt diabetes.

These metabolic conditions can also influence testosterone and estradiol physiology.

This is another reason evaluating erectile dysfunction should extend beyond simply measuring testosterone.

An erection requires more than healthy hormones and adequate blood flow.

The nervous system must first deliver the appropriate signals.

Sexual stimulation is processed within the brain, transmitted through the spinal cord, and ultimately carried through autonomic and peripheral neural pathways to the pelvis and erectile tissue.

Disruption anywhere along this pathway can contribute to neurogenic erectile dysfunction.

The location and severity of the neurologic problem can influence whether erections are absent, weakened, inconsistent, or preserved under some circumstances but not others.

The pelvic region contains several neural pathways involved in sexual function.

The pudendal nerve carries important sensory information from the penis and perineum and provides somatic motor innervation to pelvic-floor muscles involved in sexual function.

Other autonomic pelvic nerves are responsible for much of the signaling that directly regulates penile smooth muscle and blood flow.

This distinction is important because erectile function does not depend on a single “erection nerve.”

It depends on coordinated sensory, autonomic, and somatic neural pathways.

Prolonged bicycle riding is an interesting example of how mechanical pressure can potentially affect sexual function.

Traditional bicycle saddles can place substantial pressure on the perineum—the area between the genitals and anus.

Depending on riding position, saddle design, duration, and individual anatomy, this pressure may compress structures traveling through the perineal region, including pudendal neural and vascular structures.

Pelvic surgery provides another important example.

The autonomic nerves involved in erection travel through the pelvis in close proximity to structures such as the prostate.

During procedures such as radical prostatectomy, these nerves can be injured, stretched, inflamed, or otherwise affected even when nerve-sparing surgical techniques are used.

This is why erectile dysfunction can develop after prostate or other pelvic surgery even when testosterone levels and the penile vascular anatomy were normal before the procedure.

Recovery can vary considerably depending on the procedure, degree of nerve injury, age, preoperative erectile function, vascular health, and other factors.

Diabetes demonstrates why erectile dysfunction often cannot be assigned to a single category.

Chronically elevated blood glucose can damage peripheral nerves while simultaneously contributing to endothelial dysfunction and vascular disease.

This overlap is one reason ED associated with longstanding diabetes can be more difficult to treat.

Nerve dysfunction is not always all-or-nothing.

Depending on which pathways are affected, a man may retain some types of erections while having difficulty with others.

The pattern can sometimes provide clues about which portions of the neurologic pathway may be affected.

Ultimately, erectile function depends on communication between the brain, spinal cord, peripheral nerves, autonomic nervous system, pelvic structures, and blood vessels.

Performance anxiety is only one psychological contributor.

These factors can affect sexual desire, attention, arousal, autonomic nervous-system activity, and ultimately erectile function.

A man may therefore have normal testosterone, appropriate estradiol, healthy penile anatomy, and adequate vascular capacity yet still experience significant erectile difficulties under certain circumstances.

Spontaneous erections during sleep and upon awakening can sometimes provide clues about erectile physiology.

If a man continues to experience strong spontaneous or morning erections but consistently has difficulty during sexual activity, situational or psychological factors may deserve greater consideration.

Conversely, a progressive loss of spontaneous erections may increase suspicion for hormonal, vascular, neurologic, sleep-related, medication-related, or other physiologic contributors.

Morning erections alone cannot diagnose the cause of ED.

They are simply another piece of information that can help establish the overall pattern.

Medication history is another important part of an ED evaluation.

Certain medications may contribute to sexual dysfunction in some patients.

Hormonal medications should also be considered.

Testosterone dosing, aromatase inhibitors, medications affecting prolactin, and other endocrine therapies can potentially alter sexual function.

Someone should not simply stop a prescribed medication because erectile dysfunction develops.

Instead, medications should be reviewed as one potential contributor within the larger clinical picture.

Alcohol provides an interesting example of how psychological and physiological factors can pull in opposite directions.

A small amount of alcohol may decrease inhibition or anxiety in some individuals.

But larger amounts can impair neurologic signaling, reduce sexual responsiveness, and make maintaining an erection more difficult.

Chronic excessive alcohol consumption can also affect hormonal, neurologic, cardiovascular, and liver health.

So while alcohol may make someone feel psychologically more relaxed, it does not necessarily improve the physiology required for an erection.

But testosterone cannot necessarily correct significant arterial disease, diabetic neuropathy, medication effects, pelvic nerve injury, severe performance anxiety, relationship difficulties, or other causes of erectile dysfunction.

This explains something we commonly see clinically:
A man’s testosterone can be optimized while erectile dysfunction remains.

That does not necessarily mean testosterone therapy failed.

It may mean testosterone was only one component of the problem.

Likewise, changing estradiol levels without understanding the rest of the physiology may not solve the problem either.

Phosphodiesterase type 5 inhibitors—commonly called PDE5 inhibitors (Tadalafil, Sildenafil, etc)—work much closer to the vascular mechanism responsible for penile rigidity.

During sexual stimulation, nitric oxide signaling increases cGMP within erectile tissue.

An enzyme called phosphodiesterase type 5 breaks down cGMP.

PDE5 inhibitors slow this breakdown, allowing the cGMP signal to persist longer and supporting smooth-muscle relaxation and penile blood flow.

They therefore work through a fundamentally different mechanism than testosterone therapy.

Importantly, these medications generally still require sexual stimulation.

They facilitate the body’s erectile response; they do not necessarily create sexual desire or eliminate psychological barriers to arousal.

This helps explain why a man can take an ED medication and still struggle with erections if severe anxiety, inadequate stimulation, relationship difficulties, or other factors interfere with sexual arousal.

For men with both a hormonal abnormality and erectile dysfunction, treatment does not necessarily have to be an either-or decision.

Correcting clinically significant testosterone deficiency may address one component while another therapy addresses vascular erectile function.

Similarly, appropriate management of estradiol, prolactin, or thyroid dysfunction may be relevant in selected patients.

Medication may improve penile blood flow while addressing performance anxiety, metabolic health, sleep, medication effects, or other contributing factors improves another part of the problem.

The same behaviors that influence cardiovascular and metabolic health can influence erectile function.

These interventions are not simply generic wellness advice.

Erectile function depends on vascular, metabolic, neurologic, hormonal, and psychological health.

Improving those systems may support erectile function while simultaneously improving broader health.

Failure to respond to an ED medication does not automatically mean the condition is untreatable.

Sometimes correcting one of these factors changes the response.

For men who continue to experience ED, additional treatment options may include vacuum erection devices, intracavernosal injection therapy, pelvic-floor rehabilitation, selected device-based approaches, and penile prosthesis surgery for appropriate patients.

Interest has increased in treatments that attempt to improve the underlying vascular or structural environment of erectile tissue rather than simply producing a temporary erection.

These approaches include low-intensity shockwave therapy, platelet-rich plasma (PRP), and more recently, radiofrequency (RF) therapy such as ApexRF.

The concept behind these treatments is different from medications such as PDE5 inhibitors. Rather than temporarily enhancing the nitric oxide-cGMP pathway during sexual activity, these therapies attempt to influence blood flow, tissue remodeling, or other aspects of erectile tissue health through potential healing process. So, not treating a symptom, rather potentially address and heal the underlying cause.

However, these treatments should not all be considered equivalent. Their mechanisms are different, and the amount and quality of clinical evidence supporting each approach also differs.

Low-intensity shockwave therapy uses acoustic energy delivered to penile tissue.

It has been studied primarily in men with vasculogenic erectile dysfunction, with the proposed effects involving vascular signaling, tissue repair, and potentially the development or recruitment of small blood vessels.

Among the newer restorative approaches to ED, shockwave therapy currently has a larger published evidence base than PRP or penile radiofrequency therapy.

Results are not universal, treatment protocols vary, and patient selection appears to matter.

PRP uses a concentrated preparation of a patient’s own platelets, which contain growth factors and signaling molecules involved in tissue repair.

When used for male sexual health—sometimes referred to as a P-Shot—PRP is injected into penile tissue with the goal of supporting tissue healing, vascular function, and erectile response.

The biological rationale is interesting, but clinical evidence for PRP specifically for erectile dysfunction remains limited.

PRP should therefore be considered an investigational or emerging therapy for ED, rather than an established replacement for conventional treatments.

A newer strategy uses controlled radiofrequency energy to heat targeted penile and perineal tissues.

ApexRF by InMode is one example of this approach.

Unlike shockwave therapy, which uses acoustic energy, ApexRF delivers controlled bipolar radiofrequency energy.

This last point is particularly interesting when considering erectile physiology.

As discussed earlier, achieving an erection requires adequate arterial inflow, but maintaining an erection also requires the corpora cavernosa to expand sufficiently to compress venous outflow against the tunica albuginea.

Collagen and connective-tissue architecture therefore contribute to the structural mechanics involved in maintaining penile rigidity.

Radiofrequency therapy has a well-established history in other areas of medicine for controlled tissue heating and collagen remodeling. Its application specifically to erectile dysfunction, however, is relatively new.

Early clinical data are encouraging but preliminary. A small prospective pilot study presented in 2026 evaluated six weekly ApexRF treatments in men with organic or vasculogenic ED and reported improvement in erectile-function scores without reported adverse events in the initial cohort.

Much larger, controlled studies will be necessary to determine which patients are most likely to benefit, how durable improvements are, and how radiofrequency compares with established ED treatments.

Importantly, ApexRF is not currently FDA-cleared specifically for the treatment of erectile dysfunction. Its use for ED should therefore be discussed with patients as an emerging application of the technology rather than as an established or guaranteed treatment.

It can be tempting to group shockwave, PRP, and radiofrequency together as “regenerative” ED treatments, but they are not the same therapy.

These approaches may eventually prove useful alone or in combination for selected patients, but the evidence continues to evolve.

Most importantly, none of them eliminates the need to understand why a patient has erectile dysfunction in the first place.

A treatment aimed at penile blood flow or tissue remodeling is unlikely to correct ED caused primarily by severe performance anxiety, significant testosterone deficiency, neurologic injury, medication effects, or another unrelated mechanism.

As with the rest of erectile dysfunction treatment:
The therapy should be matched to the underlying physiology rather than assuming every man with ED has the same problem.

Testosterone is important for male sexual health.

So is estradiol.

And depending on the individual, prolactin, thyroid function, and other hormonal signals may also matter.

But erectile dysfunction is not simply a hormone problem.

Too much sympathetic activation at the wrong time—such as during anxiety or performance pressure—can interfere with the physiology required to maintain an erection.

A disruption anywhere within this larger system can affect erectile function.

Sometimes testosterone is part of the answer.

Sometimes another hormonal issue contributes.

Sometimes the problem is vascular.

Sometimes it is metabolic.

Sometimes it is neurologic.

Sometimes it is medication-related.

Sometimes psychological or relationship factors play a major role.

And frequently, several of these factors overlap.

Most importantly, erectile dysfunction can occasionally provide an early clue that something beyond sexual function deserves attention.

The goal should not simply be to produce a better erection.

At R2 Medical Clinic in Denver, Colorado, we take a comprehensive approach to men’s sexual health.

Evaluation may include testosterone and estradiol assessment, additional hormonal testing when clinically appropriate, metabolic and cardiovascular risk factors, medication review, lifestyle factors, psychological and situational contributors, and other potential causes of erectile dysfunction.

Treatment is individualized and may include hormone optimization when clinically appropriate, prescription ED medications, lifestyle interventions, and additional sexual-health therapies based on the patient’s needs and underlying physiology.

Erectile dysfunction is common—but it should not automatically be dismissed as aging or assumed to be a testosterone problem.